BackBrooklyn ImmunoTherapeutics Overview
Brooklyn ImmunoTherapeutics Inc

Brooklyn ImmunoTherapeutics Discounted Cash Flow

DCF Analysis for BTX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.45

Current Fair Value

$0.45
95.2% Downside

Overvalued by 95.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading